A Novel Model System for Understanding Anticancer Activity of Hypoxia-Activated Prodrugs.

Zhiyuan Sun, Haoqi Zhang, Jin Wu, Fangli Gao, Congcong Zhang, Xueyan Hu, Qiqi Liu, Yonghua Wei, Jie Zhuang, Xinglu Huang

Molecular pharmaceutics 2020 Jun 01

filter terms:

Reports on the comprehensive factors for design considerations of hypoxia-activated prodrugs (HAPs) are rare. We introduced a new model system composed of a series of highly water-soluble HAPs, providing a platform to comprehensively understand the interaction between HAPs and hypoxic biosystems. Specifically, four kinds of new HAPs were designed and synthesized, containing the same biologically active moiety but masked by different bioreductive groups. Our results demonstrated that the activity of the prodrugs was strongly dependent on not only the molecular structure but also the hypoxic tumor microenvironment. We found the presence of a direct linear relationship between cytotoxicity of the HAPs and the reduction potential of whole molecule/oxygen concentration/reductase expression. Moreover, limited blood vasculature in hypoxic regions was also a critical barrier for effective activation of the HAPs. This study offers a comprehensive insight into understanding the design factors required for HAPs.

Citation

Zhiyuan Sun, Haoqi Zhang, Jin Wu, Fangli Gao, Congcong Zhang, Xueyan Hu, Qiqi Liu, Yonghua Wei, Jie Zhuang, Xinglu Huang. A Novel Model System for Understanding Anticancer Activity of Hypoxia-Activated Prodrugs. Molecular pharmaceutics. 2020 Jun 01;17(6):2072-2082